<DOC>
	<DOCNO>NCT01072097</DOCNO>
	<brief_summary>This placebo control trial investigate effect 6 month atorvastatin 20mg/day therapy androgen , glucose metabolism inflammatory marker woman PCOS . We assume 6 month atorvastatin therapy significant improvement hyperandrogenism , glucose metabolism inflammatory marker observe .</brief_summary>
	<brief_title>The Effect Atorvastatin Androgens , Glucose Metabolism Inflammation Polycystic Ovary Syndrome ( PCOS ) Women</brief_title>
	<detailed_description>30 woman diagnose PCOS ( age 30-50 year ) enrol study . 15 woman randomize atorvastatin group 15 placebo group . The woman PCOS participate study require use safe non-hormonal contraception medication . The study include transvaginal ultrasonography , serum sample , oral glucose tolerance test ( OGTT ) intra venous tolerance test ( IVGTT ) receive 6 month atorvastatin 20mg/day therapy placebo . Measurements androgen level , pituitary hormone , glucose , insulin inflammatory marker perform .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<criteria>diagnose PCOS ( Rotterdam criterion ) age 3050 year safe nonhormonal contraception use cholesterol lower agent use antidepressant use cortisone medication ( p.o . ) use hormonal contraception nursing pregnancy DMT2 liver disease menopause kidney liver failure</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>PCOS</keyword>
	<keyword>Atorvastatin</keyword>
	<keyword>Androgens</keyword>
	<keyword>Glucose metabolism</keyword>
	<keyword>Inflammatory marker</keyword>
</DOC>